Andreas Haupt,Jürgen Dinges,Liliane Unger,Karsten Wicke,Robert van Waterschoot,Scott Mittelstadt,Karla Drescher,Ana Relo
申请号：
US14051626
公开号：
US09376396B2
申请日:
2013.10.11
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to novel acylaminocycloalkyl compounds, in particular to the compounds of the formula I as described herein and to their salts and N-oxides. The compounds possess valuable therapeutic properties and are suitable, in particular, for treating diseases that respond to modulation of the dopamine D3 receptor.
